Document is current
Any future updates will be listed below
-
Authors
Bolborea, Matei
Vercruysse, Pauline
Daria, Tselmen
Reiners, Johanna C.
Alami, Najwa Ouali
Guillot, Simon J.
Dieterlé, Stéphane
Sinniger, Jérôme
Scekic-Zahirovic, Jelena
Londo, Amela
Arcay, Hippolyte
Goy, Marc-Antoine
de Tapia, Claudia Nelson
Thal, Dietmar R.
Shibuya, Kazumoto
Otani, Ryo
Arai, Kimihito
Kuwabara, Satoshi
Ludolph, Albert C.
Roselli, Francesco
Yilmazer-Hanke, Deniz https://orcid.org/0000-0003-1483-0286
Dupuis, Luc https://orcid.org/0000-0002-0902-5824
-
Funding
Funding for this research was provided by:
Fondation Bettencourt Schueller (Coup d'élan 2019)
FRM
AXA Research Fund
USIAS
Universität Ulm
- License Information
-
More Information
Article History
Received: 16 December 2022
Revised: 29 March 2023
Accepted: 30 March 2023
First Online: 14 April 2023
Declarations
:
: DRT received speaker honorary or travel reimbursement from Novartis Pharma AG (Basel, Switzerland), UCB (Brussels, Belgium), and GE Healthcare (Amersham, UK), and collaborated with Novartis Pharma AG (Basel, Switzerland), Probiodrug (Halle (Saale), Germany), GE Healthcare (Amersham, UK), and Janssen Pharmaceutical Companies (Beerse, Belgium). DRT serves in the editorial board of Acta Neuropathologica but was not involved in the handling of this manuscript at any stage. LD reports having sponsored research agreements with Inflectis Bioscience and Cytokinetics. Other authors declare that they have no competing interests.
